Changing patterns and surgical results in adenocarcinoma of the oesophagus

British Journal of Surgery

Volumn 84, Issue 1, 1997, Pages 119-125

  Thomas, P ^a   Doddoli, C ^a   Lienne, P ^a   Morati, N ^a   Thirion, X ^a   Garbe, L ^a   Giudicelli, R ^a   Fuentes, P ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FRANCE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; BARRETT ESOPHAGUS; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LENGTH OF STAY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031015844     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840143     Document Type: Article

References (35)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
2. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993; 270: 1320 (Letter).
3. Lund O. Hasenkam JM. Aagaard MT, Kimose HH. Timerelated changes in characteristics of prognostic significance in carcinomas of the oesophagus and cardia. Br J Surg 1989; 76: 1301-7.
4. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
5. Ollyo JB, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux oesophagitis. Gullet 1993; 3: 3-10.
6. Spechler SJ. Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? Ann Intern Med 1987; 106: 902-4.
7. Fein R, Kelsen DP, Geller N, Bains M, McCormack P, Brennan MF. Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy. Cancer 1985; 56: 2512-18.
8. Gregory P, Bhathal PS, Abbott RN, Thomas RJS, Morstyn G. Clinical and pathologic similarity between adenocarcinoma of Barrett's esophagus and gastric cardia. Diseases of the Oesophagus 1989; 2: 191-6.
9. Union Internationale Contre la Cancrum (UICC). TNM Classification des Tumeurs Malignes. 4ème éd. Paris: Springer, 1988: 42-8.
10. Sielezneff I, Thomas P, Giovannini M, Giudicelli R, Seitz JF, Fuentes P. Esophageal carcinoma with doubtful extirpability. Value of preoperative chemotherapy plus radiotherapy. Eur J Cardiothorac Surg 1993; 7: 606-11.
11. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's oesophagus. Dig Dis Sci 1992; 37: 137-43.
12. Streitz JM Jr, Williamson WA, Ellis FH Jr. Current concepts concerning the nature and treatment of Barrett's esophagus and its complications. Ann Thorac Surg 1992; 54: 586-91.
13. Altorki NK, Sunagawa M, Little AG, Skinner DB. Highgrade dysplasia in the columnar-lined esophagus. Am J Surg 1991; 161: 97-9.
14. Pera M, Trastek VF, Carpenter HA. Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992; 54: 199-204.
15. Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993; 88: 1832-6.
16. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993; 105: 383-8.
17. Peters JH, Clark GWB, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108: 813-22.
18. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105: 40-50.
19. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102: 1212-19.
20. Rice TW, Goldblum JR, Falk GW, Tubbs RR, Kirby TJ, Casey G. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma. J Thorac Cardiovasc Surg 1994; 108: 1132-7.
21. Ribet M, Mensier E, Pruvot FR. Barrett's esophagus and adenocarcinoma. Eur J Cardiothorac Surg 1987; 1: 29-32.
22. Orringer MB. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 1984; 200: 282-8.
23. Peracchia A, Bardini R. Total esophagectomy without thoracotomy: results of an European questionnaire (GEEMO). Int Surg 1986; 71: 171-5.
24. Giuli R, Sancho-Garnier H. Diagnostic, therapeutic and prognostic features of cancers of esophagus: results of the international prospective study conducted by the OESO group (790 patients). Surgery 1986; 99: 614-22.
25. Lerut T, De Leyn P, Coosmans W, Van Raemdonck D, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216: 583-90.
26. Hagen JA, Peters JH, DeMeester TR. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993; 106: 850-9.
27. Clark GWB, Peters JH, Ireland AP et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994; 58: 646-54.
28. Launois B, Bourdonnec P, Bardaxoglou E et al. The influence of the extent of the gastrectomy on survival in adenocarcinoma of the cardia. Diseases of the Oesophagus 1993; 6: 41-6.
29. Couraud L, Velly JF, Clerc P, Martigne C. Experience of partial oesophagectomy in surgical treatment of lower and middle thoracic oesophageal cancer. From a follow-up of 366 cases. Eur J Cardiothorac Surg 1989; 3: 99-104.
30. Bumm R, Wong J. Extent of lymphadenectomy in oesophagectomy for squamous cell esophageal carcinoma: how much is necessary? Diseases of the Oesophagus 1994; 7: 151-5.
31. Stewart JR, Hoff SJ, Johnson DH et al. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 1993; 218: 571-8.
32. Wright CD, Mathisen DJ, Wain JC et al. Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction. Ann Thorac Surg 1994; 58: 1574-9.
33. Elias D, Lasser P, Hatchouel JM et al. Etude multifactorielle prospective des facteurs pronostiques de 200 cancers épidermoïdes de l'oesophage opérés. Définition des malades tirant bénéfice de l'exérèse chirurgicale. Gastroenterol Clin Biol 1993; 17: 17-25.
34. Gertsch P, Vauthey JN, Lustenberger AA, Friedlander-Klar H. Long-term results of transhiatal esophagectomy for esophageal carcinoma. A multivariate analysis of prognostic factors. Cancer 1993; 72: 2312-19.
35. Lieberman MD, Shriver CD, Bleckner S, Burt M, Thoracic and Gastric and Mixed Tumor Services. Carcinoma of the esophagus. Prognostic significance of histologic type. J Thorac Cardiovasc Surg 1995; 109: 130-9.